JP2016533507A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533507A5
JP2016533507A5 JP2016545238A JP2016545238A JP2016533507A5 JP 2016533507 A5 JP2016533507 A5 JP 2016533507A5 JP 2016545238 A JP2016545238 A JP 2016545238A JP 2016545238 A JP2016545238 A JP 2016545238A JP 2016533507 A5 JP2016533507 A5 JP 2016533507A5
Authority
JP
Japan
Prior art keywords
antigen
cell
receptor
antigen receptor
expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016545238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057672 external-priority patent/WO2015048413A1/en
Publication of JP2016533507A publication Critical patent/JP2016533507A/ja
Publication of JP2016533507A5 publication Critical patent/JP2016533507A5/ja
Pending legal-status Critical Current

Links

JP2016545238A 2013-09-30 2014-09-26 抗原受容体スクリーニングアッセイ Pending JP2016533507A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361884348P 2013-09-30 2013-09-30
US61/884,348 2013-09-30
PCT/US2014/057672 WO2015048413A1 (en) 2013-09-30 2014-09-26 Antigen receptor screening assay

Publications (2)

Publication Number Publication Date
JP2016533507A JP2016533507A (ja) 2016-10-27
JP2016533507A5 true JP2016533507A5 (cg-RX-API-DMAC10.html) 2017-11-02

Family

ID=52744492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545238A Pending JP2016533507A (ja) 2013-09-30 2014-09-26 抗原受容体スクリーニングアッセイ

Country Status (6)

Country Link
US (2) US20160238613A1 (cg-RX-API-DMAC10.html)
EP (1) EP3052935A4 (cg-RX-API-DMAC10.html)
JP (1) JP2016533507A (cg-RX-API-DMAC10.html)
CN (1) CN105793705A (cg-RX-API-DMAC10.html)
CA (1) CA2924603A1 (cg-RX-API-DMAC10.html)
WO (1) WO2015048413A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11851679B2 (en) 2017-11-01 2023-12-26 Juno Therapeutics, Inc. Method of assessing activity of recombinant antigen receptors
AU2020218446B2 (en) * 2019-02-04 2023-05-25 National University Corporation Ehime University "CAR LIBRARY AND scFv MANUFACTURING METHOD

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866341A (en) * 1996-04-03 1999-02-02 Chugai Pharmaceutical Co., Ltd. Compositions and methods for screening drug libraries
CA2505924A1 (en) * 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
US20050208627A1 (en) * 2003-09-18 2005-09-22 Bowdish Katherine S Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
US8298780B2 (en) * 2003-09-22 2012-10-30 X-Body, Inc. Methods of detection of changes in cells
US7271245B2 (en) * 2004-02-13 2007-09-18 The Scripps Research Institute Methods and compositions for inhibition of metastasis
FR2894983B1 (fr) * 2005-12-16 2012-08-17 Lab Francais Du Fractionnement Test de caracterisation des anticorps.
EP2046829A4 (en) * 2006-07-27 2010-05-12 Coca Cola Co MODEL TASTING CELLS AND METHOD FOR IDENTIFYING TASTE RECYCLING MODULATORS
US8008031B2 (en) * 2007-12-19 2011-08-30 National Pingtung University Of Science And Technology Competitive receptor binding assay for detecting beta-glucans
US20120107840A1 (en) * 2008-04-09 2012-05-03 Sru Biosystems, Inc Methods for Label Free Testing of Cells
JP5334269B2 (ja) * 2008-05-12 2013-11-06 独立行政法人理化学研究所 イヌ又はヒトの抗原特異的ＩｇＥを定量する方法
CA2744103C (en) * 2009-02-24 2018-01-02 Esbatech, An Alcon Biomedical Research Unit Llc Methods for identifying immunobinders of cell-surface antigens
CN102460171A (zh) * 2009-05-15 2012-05-16 Sru生物系统公司 细胞群和混合细胞群变化的检测
JP5903381B2 (ja) * 2010-07-30 2016-04-13 シスメックス株式会社 抗ｆｄｐモノクローナル抗体、それを用いたｆｄｐ測定用試薬及び試薬キット、並びにｆｄｐ測定方法
EP3798236B1 (en) * 2011-03-15 2022-08-10 X-Body, Inc. Antibody screening methods

Similar Documents

Publication Publication Date Title
CY1123708T1 (el) Αντισωματα που συνδεονται προς τον ανθρωπινο προσδετη 1 (pd-l1) προγραμματισμενου θανατου
TR201910213T4 (tr) Disülfürle stabilize edilmiş çok değerlikli antikorlar.
BR112018070823A2 (pt) anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno.
HRP20250850T1 (hr) Antitijela protiv claudina 18.2 korisna u dijagnozi raka
NZ716369A (en) Anti-ox40 antibodies and methods of using the same
BRPI0821682A2 (pt) Anticorpo monoclonal ou uma sua porção ligante de antígeno, composição farmacêutica, métodos para tratar uma doença imunológica e para produzir o anticorpo monoclonal ou sua porção ligante de antígeno, linhagem de célula isolada, molécula de ácido nucleico isolada, vetor, célula hospedeira, e, processo para identificar anticorpos anti-mif.
JP2009517695A5 (cg-RX-API-DMAC10.html)
RU2016103262A (ru) Способы идентификации иммунных связующих веществ поверхностных антигенов клетки
BRPI0507433A (pt) anticorpo monoclonal humano isolado ou sua parte de ligação ao antìgeno, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão, célula hospedeira, kit, e, métodos para tratar doença de c. difficile em um indivìduo e para tratar uma doença ou distúrbio associado a c. difficile em um mamìfero
HRP20192218T1 (hr) Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
BR112013027420A2 (pt) "uso de camundongos geneticamente modificados na preparação de um anticorpo e método para produzir anticorpos".
JP2016519932A5 (cg-RX-API-DMAC10.html)
Matsui et al. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products
O'Kennedy et al. Don't blame it all on antibodies–The need for exhaustive characterisation, appropriate handling, and addressing the issues that affect specificity
Ayriss et al. High-throughput screening of single-chain antibodies using multiplexed flow cytometry
Schräml et al. Kinetic screening in the antibody development process
BRPI1013201A2 (pt) meios e métodos para reconhecer o desenvolvimento de doenças cardiovascular em um indivíduo
ATE535546T1 (de) Humane monoklonale antikörper, die spezifisch an ifg-ii binden
RU2009124225A (ru) Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis
Kim et al. Premature antibodies with rapid reaction kinetics and their characterization for diagnostic applications
Vashist Effect of antibody modifications on its biomolecular binding as determined by surface plasmon resonance
Kimble et al. Novel antibodies for identification, selection, and manipulation of T cells expressing Whitlow linker-containing CARs
JP2020515288A5 (cg-RX-API-DMAC10.html)
WO2012141792A3 (en) Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin
US20160238613A1 (en) Antigen receptor screening assay